Skip to main content

Dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders

 

 

 

CEGIR Mission Statement

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, health care providers, patients, and professional organizations.

Dr. Marc Rothenberg, MD, PhD poses with a CEGIR patient who wears a mask that reads, "Hero"

Join One of Our Research Studies

Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by rare diseases

Find a Study

Rare Research Report: September 2023

Each month, we share summaries of recent Rare Diseases Clinical Research Network (RDCRN) grant-funded publications.

Rare Research Report logo

Milk Elimination Diet Shows Promise as First-Line Therapy for Eosinophilic Esophagitis

For patients with eosinophilic esophagitis (EoE)—a chronic immune disease typically triggered by food allergens—treatment often focuses on food elimination diets. Conventional therapy involves eliminating six food groups. However, new research from the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) suggests that eliminating a single food may be just as effective. 

The Consortium of Eosinophilic Gastrointestinal Disease Researchers logo appears over a gray graphic of molecules

CEGIR’s Marc Rothenberg Receives AAAAI 2023 Distinguished Scientist Award

Marc Rothenberg, MD, PhD, has received the American Academy of Allergy, Asthma & Immunology (AAAAI) 2023 Distinguished Scientist Award. Rothenberg will be recognized during the 2023 AAAAI Annual Meeting on February 24-26.

Image
Headshot of Marc Rothenberg, MD, PhD

Get to Know Us

Learn more about CEGIR, one of 20 consortia funded by the National Institutes of Health through the Rare Diseases Clinical Research Network. Together, we are working to better understand how Eosinophilic Gastrointestinal Diseases progress and to develop improved approaches for diagnosis and treatment.
Watch Now

CEGIR Updates

Newsletter of the Consortium of Eosinophilic Gastrointestinal Disease Researchers

An update from the Consortium of Eosinophilic Gastrointestinal Disease Researchers

Learn More
Newsletter Image